pharmacovigilance
(11)
Techsol Life Sciences makes the handoffs work
A medicine needs more than good science. Techsol Life Sciences connects the databases, decisions and people that carry it through trials, safety monitoring and regulatory review.
Alphanumeric and the Art of Answering the Difficult Call
A former IT services firm found a second life in pharmaceutical communications. Its most useful lesson concerns what happens before someone picks up the phone.
RxLogix and the Trouble Between the Boxes
Drug safety has a paperwork problem with human consequences. RxLogix is betting that connecting the work matters as much as automating it.
TriNetX and the Patients Hiding in Plain Sight
A hospital can have the right patients and still miss the trial. TriNetX makes those patients count before anyone starts recruiting - and turns the same clinical records into a working research network.
Qinecsa wants drug safety out of the inbox
A medicine’s success can bury its maker in safety reports. Qinecsa has bought and built a business around getting those reports into useful shape - and giving specialists more time to read the warning signs.
CALTEK's Quiet Bet: The Best AI Strategy Starts With the Data Nobody Wants to Clean
The Fremont consultancy works where enterprise technology gets unglamorous: messy data, regulated workflows, aging applications and mobile networks that cannot afford to blink. Its pitch is simple - fix the plumbing before promising the future.
The AI that reads every medical paper so pharma's scientists don't have to
Medical teams at drug companies read maybe 10% of the evidence that matters. Sorcero built AI agents to read the other 90% - and about a third of the top 30 global pharma companies are now paying for it.
Medpace
The Cincinnati CRO built a $2.5 billion business by taking on clinical trials that young biotechs cannot run alone - and by keeping the scientists, software, labs and logistics under one roof.
3Analytics
3Analytics is building the quiet machinery behind safer drugs and devices - software that reads the literature, watches for warning signals and helps regulated teams act before a data problem becomes a patient problem.
HiRO - Harvest Integrated Research Organization
HiRO (Harvest Integrated Research Organization) is a full-service, globally oriented clinical research organization founded in 2020 that helps biotech companies run clinical trials across borders. Positioning itself as an 'integrated' rather than a traditional 'contract' research organization, HiRO connects Asian biotechs seeking trials outside their region with US and European sponsors wanting to run studies in Asia. Backed by a tens-of-millions-of-dollars Series A led by OrbiMed and built out through three CRO acquisitions, it offers end-to-end services from preclinical strategy to regulatory submission, with deep expertise in oncology and rare disease.
ClinChoice
ClinChoice is a mid-size, global, full-service contract research organization (CRO) that helps pharmaceutical, biotech, medical device, and consumer health companies run clinical trials and bring drugs and devices to market. Founded in 1995 and headquartered in Horsham, Pennsylvania, the firm employs roughly 4,000 people across the Americas, Europe, and Asia-Pacific, offering clinical development, biometrics, safety/pharmacovigilance, regulatory affairs, post-marketing real-world evidence, and technology services. After rebranding from Fountain Medical Development (FMD K&L) in 2020 and raising a $150M Series E in 2022, ClinChoice has grown through acquisitions to serve six of the top ten pharma companies while focusing on emerging and mid-size biotech innovators.